Journal Information

Most often read

21726
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024
J.M. Remes-Troche, E. Coss-Adame, M. Schmulson, K.R. García-Zermeño, M. Amieva-Balmori, R. Carmona-Sánchez, O. Gómez-Escudero, P.C. Gómez-Castaños, ... A.S. Villar-Chávez
Rev Gastroenterol Mex. 2025;90:77-110
21726
Full text access
6444
Good clinical practice recommendations for the diagnosis and treatment of functional dyspepsia: An expert review from the Asociación Mexicana de Gastroenterología
R.I. Carmona-Sánchez, G. Vázquez-Elizondo, M.C. Rodríguez-Leal, O. Gómez-Escudero, M.V. Bielsa-Fernández, E. Coss-Adame, K. García-Zermeño, P. Gómez-Castaños, ... L.R. Valdovinos-García
Rev Gastroenterol Mex. 2025;90:227-51
6444
Full text access
5074
Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociación Mexicana de Gastroenterología) - AMNM (Asociación Mexicana de Neurogastroenterología y Motilidad) expert joint review
O. Gómez-Escudero, J.M. Remes-Troche, E. Coss-Adame, K.R. García-Zermeño, J. Aquino-Matus, J. Jiménez-Pavón, L.R. Valdovinos-García, M.A. Vargas-Martínez, ... C.P. Gyawali
Rev Gastroenterol Mex. 2025;90:252-87
5074
Full text access
3435
Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG
L.R. Valdovinos-García, A.S. Villar-Chávez, F.M Huerta-Iga, M. Amieva-Balmori, J.S. Arenas-Martínez, R. Bernal-Reyes, E. Coss-Adame, O. Gómez-Escudero, ... M.R. Zavala-Solares
Rev Gastroenterol Mex. 2025;90:111-30
3435
Full text access
3279
Cannabinoid hyperemesis syndrome: A review
R.A. Jiménez-Castillo, S. Arumugam, J.M. Remes-Troche, T. Venkatesan
Rev Gastroenterol Mex. 2025;90:214-26
3279
Full text access
3162
Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study
C. von Muhlenbrock, G. Landskron, A.M. Madrid
Rev Gastroenterol Mex. 2025;90:54-62
3162
Full text access
1811
Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids
G. Mendoza-Domínguez, Z.M. Garrido-Santos, C. Lau, R. Balbuena, A.D. Santana-Vargas, M. Schmulson-Wasserman
Rev Gastroenterol Mex. 2025;90:169-75
1811
Full text access
1696
Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review
M.A. Valdovinos-Díaz, A. Hani, C. Defilippi-Guerra, L. Fernando-Pineda, J.M. Remes-Troche, A. Riquelme, L.J. Abrahão-Junior, L. Aguilar-Paiz, ... J.S. Arenas-Martínez
Rev Gastroenterol Mex. 2025;90:288-308
1696
Full text access
1612
Eosinophilic esophagitis: Current concepts of pathophysiology, diagnosis, and treatment
D. García-Compeán, A.R. Jiménez-Rodríguez, C.E. González-Martínez
Rev Gastroenterol Mex. 2025;90:63-76
1612
Full text access
1472
The role of conservative treatment in esophageal perforation caused by the ingestion of a blister pack: A case report and literature review
J.P. Pérez-Macías, M.E. Ramírez-Solís, A.Y. Ortega-Caballero, A.I. Hernández-Guerrero, E.F. Marquez-Bornio
Rev Gastroenterol Mex. 2025;90:148-51
1472
Full text access
1345
Prevalence of extraintestinal manifestations and other associated conditions in a cohort of patients with inflammatory bowel disease at an advanced specialty center in Bogotá, Colombia
J. Andrade-Restrepo, D. Rubio-Cruz, J.G. Maigual-Quintas, S.G. Sicard-Gómez, E.J. Cuello-Navarro, L.C. Álvarez-Larrota, R. García-Duperly, E.E. Londoño-Schimmer, ... R.P. López-Panqueva
Rev Gastroenterol Mex. 2025;90:44-53
1345
Full text access
856
Impact of biofeedback therapy in constipation due to dyssynergic defecation
A. Fuentes-Montalvo, A.L. Ordóñez-Vázquez, J.S. Arenas-Martínez, E. Coss-Adame
Rev Gastroenterol Mex. 2025;90:311-3
856
Full text access
855
Transitioning from NAFLD to MAFLD to MASLD in the Mexican population
B.A. Priego-Parra, R. Bernal-Reyes, M.E. Icaza-Chávez, S.E. Martínez-Vázquez, J.M. Remes-Troche
Rev Gastroenterol Mex. 2025;90:153-6
855
Full text access
846
Clinical description of adults with eosinophilic esophagitis treated at a Chilean university center
C. von Muhlenbrock, P. Núñez, R. Quera, J. Venegas, N. Pacheco, K. Herrera, F. Castro
Rev Gastroenterol Mex. 2025;90:8-14
846
Full text access
823
Eosinophilic esophagitis: Current state and perspectives in Latin America
D. García-Compeán
Rev Gastroenterol Mex. 2025;90:4-7
823
Full text access
821
Comparison of the predictive capacity of the Alvarado and AIR scores in the diagnosis of acute appendicitis: A prospective study
L.M. Sanabria-Arévalo, L.C. Domínguez-Torres, J. Kock, J.D. Lotero, J.C. Gómez-Cáceres, E. Tuta-Quintero
Rev Gastroenterol Mex. 2025;90:176-81
821
Full text access
816
Elevated fecal calprotectin: Does capsule endoscopy have a role in the diagnostic algorithm?
S. Vibhishanan, P. Oka, S. Zammit, R. Sidhu
Rev Gastroenterol Mex. 2025;90:29-35
816
Full text access
761
Characterization of the epidemiologic, pathologic, radiologic, and management profile of patients with gastrointestinal stromal tumors (GISTs): A 5-year Chilean experience
G. Schiappacasse, R. Cocio, J. Cristi, J. Torres, F. Aliaga, M. Vial, J. Hepp, A. Castiblanco
Rev Gastroenterol Mex. 2025;90:15-21
761
Full text access
718
Hemostatic powder efficacy for the endoscopic management of malignant upper gastrointestinal bleeding
J.P. Pérez-Macías, M.E. Ramírez-Solís, A.I. Hernández-Guerrero, J.G. Dela Mora-Levy, W.D. Torrecilla-Ramírez, B.A. Sánchez-Jiménez, G.M. Salgado-Castellón
Rev Gastroenterol Mex. 2025;90:199-206
718
Full text access
Idiomas
Revista de Gastroenterología de México
es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.